[go: up one dir, main page]

Tischendorf et al., 1970 - Google Patents

Oz-Markers: Their Occurrence in Subtypes of Human Lambda Immunoglobulin Chains

Tischendorf et al., 1970

Document ID
1078372351931187896
Author
Tischendorf F
Tischendorf M
Publication year
Publication venue
Protides of the Biological Fluids

External Links

Snippet

Publisher Summary This chapter discusses the occurrence of Oz-marker in subtypes of human lambda immunoglobulin chains. Antibody diversity is the result of three types of amino acid sequence variability, which include isotypy, allotypy, and idiotypy. Two major …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
Buus et al. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides
Schwartz et al. H-2 Histocompatibility alloantigens. Biochemical properties of the molecules solubilized by NP-40 detergent
Mimuro et al. Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix: evidence that the protein is vitronectin
Schulze-Koops et al. Plasmid-encoded outer membrane protein YadA mediates specific binding of enteropathogenic yersiniae to various types of collagen
Wong et al. Structural and enzymological characterization of immunoaffinity-purified DNA polymerase alpha. DNA primase complex from KB cells.
Kellogg et al. RNA codons and protein synthesis. IX. Synonym codon recognition by multiple species of valine-, alanine-, and methionine-sRNA.
Capra et al. Light chain sequences of human IgM cold agglutinins
ID16512A (en) MODIFIED / ALL MODIFIED SUPERANTIGENTS AND ITS USE
KR960700739A (en) HLA-A2. 1 binding peptide and uses thereof (HLA-A2.1 BINDING PEPTIDES AND THEIR USES)
Strong et al. Isolation, characterization and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle
AU1342888A (en) Molecules comprising at least one peptidic sequence carrying one or a plurality of epitopes characterizing a protein produced by P.Falciparum in hepatocytes and compositions containing them
US5663066A (en) Assay using recombinant histidyl-tRNA synthetase
Fahnestock Cloned streptococcal protein G genes
EP1950221A3 (en) Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis
Tischendorf et al. Oz-Markers: Their Occurrence in Subtypes of Human Lambda Immunoglobulin Chains
Kataoka et al. Secretion of functional salivary peptide by Streptococcus gordonii which inhibits fimbria-mediated adhesion of Porphyromonas gingivalis
Bahr et al. An association between Gc (vitamin D-binding protein) alleles and susceptibility to rheumatic fever
Van Schravendijk et al. Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1.
Krueger et al. Protease treatment of pertussis toxin identifies the preferential cleavage of the S1 subunit
DE69311796D1 (en) PEPTIDES OF THE CASEINOMACROPEPTID, ANTIBODIES AGAINST IT AND THEIR APPLICATIONS
ATE435915T1 (en) SPECIFIC NUCLEIC ACIDS AND POLYPEPTIDES FROM DISEASE CAUSING STRAINS OF NEISSERIA
Devaney et al. Immunological cross-reactivity between carbamyl phosphate synthetases I, II, and III.
Kemp et al. The immune response to human type III and type V (AB2) collagen: antigenic determinants and genetic control in mice
KR950000730A (en) Novel peptides and DNAs encoding them
Plunkett et al. Biochemical evidence for trans complementation of structural genes in the expression of IE antigens in F1 hybrids.